Q4 2013 Regeneron Pharmaceutica Earnings Conference call (Webcast)

Regeneron Pharmaceuticals, Inc. (REGN): Q4 EPS of $2.24 beats by $0.16. Revenue of $610M (+47.0% Y/Y) beats by $30.83M.

The following audio is from a conference call that will begin on February 11, 2014 at 08:30 AM ET. The audio will stream live while the call is active, and can be replayed upon its completion.

If you would like to view a transcript of this call, please click here.